208 related articles for article (PubMed ID: 31714036)
21. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
[TBL] [Abstract][Full Text] [Related]
22. Review of the cervical cancer disease burden in mainland China.
Li J; Kang LN; Qiao YL
Asian Pac J Cancer Prev; 2011; 12(5):1149-53. PubMed ID: 21875257
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus-associated cancers - United States, 2004-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
Kim JJ; Simms KT; Killen J; Smith MA; Burger EA; Sy S; Regan C; Canfell K
PLoS Med; 2021 Mar; 18(3):e1003534. PubMed ID: 33705382
[TBL] [Abstract][Full Text] [Related]
27. [Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women].
Zhao Y; Zhao F; Hu S; Chen W; Chen F; Cui J; Liu B; Zhang W; Zhang X; Pan Q; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1351-6. PubMed ID: 26850387
[TBL] [Abstract][Full Text] [Related]
28. Cancers attributable to human papillomavirus infection.
Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
[TBL] [Abstract][Full Text] [Related]
29. Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.
Zhang Q; Liu YJ; Hu SY; Zhao FH
BMC Cancer; 2016 Nov; 16(1):848. PubMed ID: 27814703
[TBL] [Abstract][Full Text] [Related]
30. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
31. Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
Deshmukh AA; Suk R; Shiels MS; Damgacioglu H; Lin YY; Stier EA; Nyitray AG; Chiao EY; Nemutlu GS; Chhatwal J; Schmeler K; Sigel K; Sonawane K
J Natl Cancer Inst; 2021 Jun; 113(6):792-796. PubMed ID: 32833021
[TBL] [Abstract][Full Text] [Related]
32. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
Xu QX; Zhang ZY
Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
[TBL] [Abstract][Full Text] [Related]
33. Detection of human papillomavirus high-risk genotypes in rural women of Lucknow, North India.
Srivastava AN; Misra JS; Rizvi S
J Cancer Res Ther; 2021; 17(6):1468-1472. PubMed ID: 34916379
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
[TBL] [Abstract][Full Text] [Related]
35. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
37. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
Aljunid S; Zafar A; Saperi S; Amrizal M
Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
[TBL] [Abstract][Full Text] [Related]
38. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
Hansen BT; Campbell S; Nygård M
BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
40. [Report of cancer epidemiology in China, 2015].
Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen R; Gu XY; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):19-28. PubMed ID: 30678413
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
